Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
LARONIDASE
Aldurazyme
Hurler-Scheie Syndrome
ALID02003NAEudraCT: 2015-000585-61Tabulated Results
LARONIDASE
Aldurazyme
Hurler-Scheie Syndrome
ALID02307NANCT00741338Tabulated Results
LARONIDASE
Aldurazyme
Hurler-Scheie Syndrome
BIO7500-001*NASummary
LARONIDASE
Aldurazyme
Mucopolysaccharidosis I
LPS16578NAEudraCT Number: 2023-001027-16Tabulated results
LARONIDASE
Aldurazyme
Mucopolysaccharidosis I; Hurler's Syndrome; Hurler-Scheie Syndrome; Scheie
OBS12874/ALID01803NANCT00418821Tabulated Results
LAROTAXEL
Not Marketed
Breast Neoplasms
EFC10073SATINEudraCT: 2006-006473-24Summary Results
LAROTAXEL
Not Marketed
Breast Neoplasms
EFC6088NANCT00087958Summary
LAROTAXEL
Not Marketed
Breast Neoplasms
EFC6089NANCT00081796Summary
LAROTAXEL
Not Marketed
Pancreatic Neoplasms
EFC6596PAPRIKAEudraCT: 2006-003086-14Summary Results
LAROTAXEL
Not Marketed
Urinary Bladder Neoplasms
EFC6668CILABEudraCT: 2007-001943-23Summary Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted